AI Bias Analysis
4 models · Takes ~15 seconds
Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
Source
Stat News
Opens original article in a new tab
The Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning Rounds
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.
Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.
The arbitration process has protected patients but generated financial windfalls for some clinicians.
